Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group

Sandra Orchard; Bissan Al-Lazikani; Steve Bryant; Dominic Clark; Elizabeth Calder; Ian Dix; Ola Engkvist; Mark Forster; Anna Gaulton; Michael Gilson; Robert Glen; Martin Grigorov; Kim Hammond-Kosack; Lee Harland; Andrew Hopkins; Christopher Larminie; Nick Lynch; Romeena K. Mann; Peter Murray-Rust; Elena Lo Piparo; Christopher Southan; Christoph Steinbeck; David Wishart; Henning Hermjakob; John Overington; Janet Thornton

doi:10.1038/nrd3503-c2

Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group

Sandra Orchard, Bissan Al-Lazikani, Steve Bryant, Dominic Clark, Elizabeth Calder, Ian Dix, Ola Engkvist, Mark Forster, Anna Gaulton, Michael Gilson, Robert Glen, Martin Grigorov, Kim Hammond-Kosack, Lee Harland, Andrew Hopkins, Christopher Larminie, Nick Lynch, Romeena K. Mann, Peter Murray-Rust, Elena Lo PiparoChristopher Southan, Christoph Steinbeck, David Wishart, Henning Hermjakob, John Overington, Janet Thornton

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	730
Number of pages	1
Journal	Nature Reviews Drug Discovery
Volume	11
Issue number	9
DOIs	https://doi.org/10.1038/nrd3503-c2
State	Published - Sep 2012
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

10.1038/nrd3503-c2

Cite this

Orchard, S., Al-Lazikani, B., Bryant, S., Clark, D., Calder, E., Dix, I., Engkvist, O., Forster, M., Gaulton, A., Gilson, M., Glen, R., Grigorov, M., Hammond-Kosack, K., Harland, L., Hopkins, A., Larminie, C., Lynch, N., Mann, R. K., Murray-Rust, P., ... Thornton, J. (2012). Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group. Nature Reviews Drug Discovery, 11(9), 730. https://doi.org/10.1038/nrd3503-c2

Orchard, S, Al-Lazikani, B, Bryant, S, Clark, D, Calder, E, Dix, I, Engkvist, O, Forster, M, Gaulton, A, Gilson, M, Glen, R, Grigorov, M, Hammond-Kosack, K, Harland, L, Hopkins, A, Larminie, C, Lynch, N, Mann, RK, Murray-Rust, P, Piparo, EL, Southan, C, Steinbeck, C, Wishart, D, Hermjakob, H, Overington, J & Thornton, J 2012, 'Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group', Nature Reviews Drug Discovery, vol. 11, no. 9, pp. 730. https://doi.org/10.1038/nrd3503-c2

@article{aa6c7abe831a44f0a39672e8acfb2a06,

title = "Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group",

author = "Sandra Orchard and Bissan Al-Lazikani and Steve Bryant and Dominic Clark and Elizabeth Calder and Ian Dix and Ola Engkvist and Mark Forster and Anna Gaulton and Michael Gilson and Robert Glen and Martin Grigorov and Kim Hammond-Kosack and Lee Harland and Andrew Hopkins and Christopher Larminie and Nick Lynch and Mann, {Romeena K.} and Peter Murray-Rust and Piparo, {Elena Lo} and Christopher Southan and Christoph Steinbeck and David Wishart and Henning Hermjakob and John Overington and Janet Thornton",

year = "2012",

month = sep,

doi = "10.1038/nrd3503-c2",

language = "English (US)",

volume = "11",

pages = "730",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group

AU - Orchard, Sandra

AU - Al-Lazikani, Bissan

AU - Bryant, Steve

AU - Clark, Dominic

AU - Calder, Elizabeth

AU - Dix, Ian

AU - Engkvist, Ola

AU - Forster, Mark

AU - Gaulton, Anna

AU - Gilson, Michael

AU - Glen, Robert

AU - Grigorov, Martin

AU - Hammond-Kosack, Kim

AU - Harland, Lee

AU - Hopkins, Andrew

AU - Larminie, Christopher

AU - Lynch, Nick

AU - Mann, Romeena K.

AU - Murray-Rust, Peter

AU - Piparo, Elena Lo

AU - Southan, Christopher

AU - Steinbeck, Christoph

AU - Wishart, David

AU - Hermjakob, Henning

AU - Overington, John

AU - Thornton, Janet

PY - 2012/9

Y1 - 2012/9

UR - http://www.scopus.com/inward/record.url?scp=84866103348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866103348&partnerID=8YFLogxK

U2 - 10.1038/nrd3503-c2

DO - 10.1038/nrd3503-c2

M3 - Letter

AN - SCOPUS:84866103348

SN - 1474-1776

VL - 11

SP - 730

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 9

ER -

Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this